Cargando…
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
Huntington's disease (HD) is a fatal autosomal‐dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab developed a novel immune deficient HD mouse strain, the YACNSG,...
Autores principales: | Dahlenburg, Heather, Cameron, David, Yang, Sheng, Bachman, Angelica, Pollock, Kari, Cary, Whitney, Pham, Missy, Hendrix, Kyle, White, Jeannine, Nelson, Haley, Deng, Peter, Anderson, Joseph S., Fink, Kyle, Nolta, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235129/ https://www.ncbi.nlm.nih.gov/pubmed/33710799 http://dx.doi.org/10.1002/sctm.20-0431 |
Ejemplares similares
-
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
por: Deng, Peter, et al.
Publicado: (2016) -
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
por: Pollock, Kari, et al.
Publicado: (2016) -
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection
por: Zhang, Y, et al.
Publicado: (2011) -
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells
por: Zhao, N, et al.
Publicado: (2011) -
Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats
por: Arzi, Boaz, et al.
Publicado: (2016)